
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is a leading medical technology company with a strong global presence and a unique product offering in the form of the Motiva breast implant. With its impressive safety profile, natural feel, and disruptive technology, Establishment Labs has the potential to capture market share from established players in markets like the U.S. and China. Additionally, the company's minimally invasive platform and new pipeline developments are expected to drive long-term growth. With strong early demand for new products like Preservé, Establishment Labs looks well-positioned for continued success, as evidenced by its recent strong quarterly results and increased revenue guidance for 2026.
Bears say
Establishment Labs Hldgs is currently experiencing strong financial growth due to their innovative R&D and numerous market-expanding catalysts, leading to a Buy rating and an $88 price target. However, the company faces several risks, such as potential funding needs and the possibility of unsuccessful pipeline product launches, which could impact their financial performance and stock value. Additionally, competition and economic recessions may also pose risks for the company.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares